CLINICAL_TRIALS
trial_result
· 2016-03-21
Clinical Trial Update: Research Study for Major Depressive Disorder: Investigation of Glutamate Medications [Phase 4]
Summary
A Phase 4 clinical trial investigating glutamate-targeting medications for major depressive disorder has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Baylor College of Medicine | Conditions: Major Depression | Phase 4 | Status: COMPLETED | Results posted: 2016-03-21